Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Spontaneous coronary artery dissection associated with coughing.
Sivam S, Yozghatlian V, Dentice R, McGrady M, Moriarty C, Di Michiel J, Bye PT, Rees D. Sivam S, et al. Among authors: yozghatlian v. J Cyst Fibros. 2014 Mar;13(2):235-7. doi: 10.1016/j.jcf.2013.10.003. Epub 2013 Oct 21. J Cyst Fibros. 2014. PMID: 24157355 Free article. No abstract available.
Quality of home spirometry performance amongst adults with cystic fibrosis.
Bell JM, Sivam S, Dentice RL, Dwyer TJ, Jo HE, Lau EM, Munoz PA, Nolan SA, Taylor NA, Visser SK, Yozghatlian VA, Wong KK. Bell JM, et al. Among authors: yozghatlian va. J Cyst Fibros. 2022 Jan;21(1):84-87. doi: 10.1016/j.jcf.2021.10.012. Epub 2021 Nov 10. J Cyst Fibros. 2022. PMID: 34774443 Free article.
Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019.
Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Lin A, et al. Among authors: yozghatlian v. Med J Aust. 2023 Feb 20;218(3):138-139. doi: 10.5694/mja2.51797. Epub 2022 Dec 1. Med J Aust. 2023. PMID: 36453811 No abstract available.
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry.
Gibson PG, Reddel H, McDonald VM, Marks G, Jenkins C, Gillman A, Upham J, Sutherland M, Rimmer J, Thien F, Katsoulotos GP, Cook M, Yang I, Katelaris C, Bowler S, Langton D, Robinson P, Wright C, Yozghatlian V, Burgess S, Sivakumaran P, Jaffe A, Bowden J, Wark PA, Yan KY, Kritikos V, Peters M, Hew M, Aminazad A, Bint M, Guo M. Gibson PG, et al. Among authors: yozghatlian v. Intern Med J. 2016 Sep;46(9):1054-62. doi: 10.1111/imj.13166. Intern Med J. 2016. PMID: 27350385
Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.
Aaron SD, Vandemheen KL, Ferris W, Fergusson D, Tullis E, Haase D, Berthiaume Y, Brown N, Wilcox P, Yozghatlian V, Bye P, Bell S, Chan F, Rose B, Jeanneret A, Stephenson A, Noseworthy M, Freitag A, Paterson N, Doucette S, Harbour C, Ruel M, MacDonald N. Aaron SD, et al. Among authors: yozghatlian v. Lancet. 2005 Aug 6-12;366(9484):463-71. doi: 10.1016/S0140-6736(05)67060-2. Lancet. 2005. PMID: 16084254 Clinical Trial.
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria.
Hew M, Gillman A, Sutherland M, Wark P, Bowden J, Guo M, Reddel HK, Jenkins C, Marks GB, Thien F, Rimmer J, Katsoulotos GP, Cook M, Yang I, Katelaris C, Bowler S, Langton D, Wright C, Bint M, Yozghatlian V, Burgess S, Sivakumaran P, Yan KY, Kritikos V, Peters M, Baraket M, Aminazad A, Robinson P, Jaffe A, Powell H, Upham JW, McDonald VM, Gibson PG. Hew M, et al. Among authors: yozghatlian v. Clin Exp Allergy. 2016 Nov;46(11):1407-1415. doi: 10.1111/cea.12774. Epub 2016 Jul 22. Clin Exp Allergy. 2016. PMID: 27377155